These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 32949996)
21. Quercetin inhibits renal cyst growth in vitro and via parenteral injection in a polycystic kidney disease mouse model. Zhu Y; Teng T; Wang H; Guo H; Du L; Yang B; Yin X; Sun Y Food Funct; 2018 Jan; 9(1):389-396. PubMed ID: 29215110 [TBL] [Abstract][Full Text] [Related]
22. Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells. Yamaguchi T; Hempson SJ; Reif GA; Hedge AM; Wallace DP J Am Soc Nephrol; 2006 Jan; 17(1):178-87. PubMed ID: 16319189 [TBL] [Abstract][Full Text] [Related]
25. Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease. Li LX; Fan LX; Zhou JX; Grantham JJ; Calvet JP; Sage J; Li X J Clin Invest; 2017 Jun; 127(7):2751-2764. PubMed ID: 28604386 [TBL] [Abstract][Full Text] [Related]
26. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells. de Stephanis L; Bonon A; Varani K; Lanza G; Gafà R; Pinton P; Pema M; Somlo S; Boletta A; Aguiari G Clin Exp Nephrol; 2017 Apr; 21(2):203-211. PubMed ID: 27278932 [TBL] [Abstract][Full Text] [Related]
27. Drug discovery for polycystic kidney disease. Sun Y; Zhou H; Yang BX Acta Pharmacol Sin; 2011 Jun; 32(6):805-16. PubMed ID: 21642949 [TBL] [Abstract][Full Text] [Related]
28. Chronic activation of AMP-activated protein kinase leads to early-onset polycystic kidney phenotype. Wilson L; Pollard AE; Penfold L; Muckett PJ; Whilding C; Bohlooly-Y M; Wilson P; Carling D Clin Sci (Lond); 2021 Oct; 135(20):2393-2408. PubMed ID: 34622923 [TBL] [Abstract][Full Text] [Related]
29. Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease. Zafar I; Ravichandran K; Belibi FA; Doctor RB; Edelstein CL Kidney Int; 2010 Oct; 78(8):754-61. PubMed ID: 20686448 [TBL] [Abstract][Full Text] [Related]
30. A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease. Pey R; Bach J; Schieren G; Gretz N; Hafner M In Vitro Cell Dev Biol Anim; 1999; 35(10):571-9. PubMed ID: 10614866 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of Activin Signaling Slows Progression of Polycystic Kidney Disease. Leonhard WN; Kunnen SJ; Plugge AJ; Pasternack A; Jianu SB; Veraar K; El Bouazzaoui F; Hoogaars WM; Ten Dijke P; Breuning MH; De Heer E; Ritvos O; Peters DJ J Am Soc Nephrol; 2016 Dec; 27(12):3589-3599. PubMed ID: 27020852 [TBL] [Abstract][Full Text] [Related]
32. Parallel analysis of mRNA and microRNA microarray profiles to explore functional regulatory patterns in polycystic kidney disease: using PKD/Mhm rat model. Dweep H; Sticht C; Kharkar A; Pandey P; Gretz N PLoS One; 2013; 8(1):e53780. PubMed ID: 23326503 [TBL] [Abstract][Full Text] [Related]
34. A mild reduction of food intake slows disease progression in an orthologous mouse model of polycystic kidney disease. Kipp KR; Rezaei M; Lin L; Dewey EC; Weimbs T Am J Physiol Renal Physiol; 2016 Apr; 310(8):F726-F731. PubMed ID: 26764208 [TBL] [Abstract][Full Text] [Related]
35. Rosiglitazone inhibits insulin-like growth factor‑1-induced polycystic kidney disease cell growth and p70S6 kinase activation. Liu C; Zhang Y; Yuan L; Fu L; Mei C Mol Med Rep; 2013 Sep; 8(3):861-4. PubMed ID: 23864113 [TBL] [Abstract][Full Text] [Related]